Pharmaceutical Commerce

JANUARY 15, 2024

FDA approves Keytruda (pembrolizumab) combined with chemoradiation for the treatment of patients with FIGO 2014 stage III to IVA cervical cancer, which is the 39th overall approved indication for the drug in the United States.

FDA 107

FDA Patients 107

Pharmacy Times

JANUARY 15, 2024

The approval was based on the results of a phase 3 trial that found an improvement in progression-free survival among individuals treated with pembrolizumab.

FDA 49

FDA 49

Pharmaceutical Technology

SEPTEMBER 27, 2023

The idiopathic pulmonary fibrosis (IPF) market is underserved with just two licensed pharmaceutical treatments approved by the FDA in 2014.

Patients 105

Patients FDA Pharmaceutical Marketing 105

PharmExec

MARCH 13, 2024

Data shows that from 2014-2019, pneumococcal vaccinations in seniors increased by 10%, growing sales for Prevnar 13 due to government recommendation in addition to a high-profile advertising campaign.

Government 52

Government Pharmaceutical Sales 52

MedCity News

APRIL 14, 2023

Since Scene Health was founded in 2014, it has raised more than $25 million total. Scene Health’s $17.7 million Series B funding round was led by ABS Capital Partners and includes participation from Claritas Health Ventures, PTX Capital, Kapor Capital and Healthworx, the investment arm of CareFirst BlueCross BlueShield.

Medical 108

Medical 108

MedCity News

JUNE 20, 2023

Renee Dua and Nick Desai —the husband-and-wife duo who founded physician house call company Heal in 2014 — have launched another healthcare startup.

Patients 102

Patients Physicians Healthcare Healthcare 102

MedCity News

DECEMBER 26, 2022

The 17% increase is the largest jump since OIG began tracking lab spending in 2014. This increase was due to higher volume for three test types: Covid-19 tests, genetic tests and chemistry tests.

98

98

PharmExec

JANUARY 15, 2024

The FDA issued the 39th overall approval for Keytruda (pembrolizumab), with the latest in combination with chemoradiation for the treatment of patients with FIGO 2014 stage III to IVA cervical cancer.

FDA 52

FDA Patients 52

Pharmacy Times

JANUARY 16, 2024

Previously, IgG-hyaluronidase recombinant was approved by the FDA in 2014 for the treatment of primary immunodeficiency in adult patients and has expanded to include some pediatric patients.

FDA 58

FDA Patients 58

World of DTC Marketing

JANUARY 10, 2022

Data were mainly accessible for smaller firms, effects in some therapeutic regions, orphan drugs, first-in-class drugs, therapeutic agents that received accelerated approval, and products approved between 2014 and 2018. According to the study in JAMA “the FDA approved 355 new drugs and biologics over the study period.

Food and Drug Administration 213

Food and Drug Administration Pharma Marketing Food 213

World of DTC Marketing

DECEMBER 17, 2020

Another 8% said they or a family member put off treatment for a less serious condition, bringing the total percentage of households delaying care due to costs to 33%, tying the high from 2014. As 60 Minutes reported last weekend, one big chain, Sutter, has led to the most expensive childbirth in the U.S.

Healthcare 181

Healthcare Healthcare Government Physicians 181

European Pharmaceutical Review

SEPTEMBER 12, 2023

The panelists referred to other documents that are useful for CCS development: the 2014 Pharmaceutical Healthcare Sciences Society (PHSS) Technical Monograph No 20 Bio-Contamination 2 as well as the Parenteral Drug Association (PDA) Technical Report 90: Contamination Control Strategy Development, 3 published in February 2023.

Consulting 123

Consulting Biopharma Manufacturing Pharmaceutical 123

Spotio

AUGUST 1, 2022

SPOTIO has been helping solar field sales take their teams to the next level and achieve more since 2014. The Complete Guide for Solar Sales Leaders. Today, we work with hundreds of residential and commercial solar companies worldwide.

Sales 98

Sales 98

World of DTC Marketing

MARCH 31, 2022

In 2014, researchers determined, 30% of insulin revenue went to middlemen. Researchers at USC found that drugmakers’ share of revenue from insulin sales has declined in recent years — and a more significant share is being siphoned off by pharmacy benefit managers, drugstores, wholesalers, and insurers. Los Angeles Times.

Insurance 240

Insurance Prescription Manufacturing Sales 240

Pharmacy Times

DECEMBER 15, 2022

While the use of direct-acting antiviral treatment for hepatitis C virus increased from 2014 to 2018, treatment rates have declined since 2019 and remain suboptimal.

49

49

Pharmacy Times

NOVEMBER 11, 2022

Updated prescribing guidelines issued in 2014 and 2016 may explain lower use of opioids by 11.7% among patients with chronic, nonsurgical pain.

Patients 49

Patients 49

World of DTC Marketing

JANUARY 4, 2022

In 2014, cancer patients paid $4 billion out-of-pocket for cancer treatment. Cancer patients may struggle to pay out-of-pocket expenses due to the high expenses incurred, the medical debt, or loss of work. Some cancer patients may face out-of-pocket costs of nearly $12,000 a year for one drug.

Insurance 273

Insurance Transportation Medical Prescription 273

World of DTC Marketing

JANUARY 12, 2021

Recent Studies show that in 2014, 70% of the 50-65 age bracket use the internet, while 38% of those over 65 years old go online. For the first time, more than half of all online adults 65 and older (56%) use social media, Facebook in particular, according to Pew Research Center’s Social Media Update for 2014.

Patients 155

Patients Media Marketing Prescription 155

Pharmaceutical Technology

JANUARY 22, 2023

Jardiance was initially approved in 2014 as a once-a-day tablet for use with diet and exercise to reduce blood sugar in type 2 diabetes adult patients. The company stated that the drug received Fast Track designation from the US FDA for the same indication in March 2020.

Food and Drug Administration 105

Food and Drug Administration FDA Food Patients 105

pharmaphorum

JANUARY 3, 2023

After passing on the reins of NICE, he was appointed chair of the UK’s Medicines and Healthcare products Regulatory Agency (MHRA), heading up the agency for two 3-year terms between 2014 and 2020.

Side effects 52

Side effects Medicine Safety Healthcare 52

Pharma Leaders

JUNE 27, 2023

Pfizer obtained the licence for gene therapy from Spark Therapeutics in December 2014. Fidanacogene elaparvovec also demonstrated to be well-tolerated, with a safety profile in line with Phase I/II data.

Food and Drug Administration 52

Food and Drug Administration FDA Safety Engineering 52

World of DTC Marketing

MAY 26, 2021

net revenue for Imbruvica has increased from $492 million in 2014 to $4.3 billion in Imbruvica net revenue from Medicare Part D between 2014 and 2018. AbbVie’s yearly U.S. net revenue from Humira more than tripled from $5.3 billion in 2013—the year it separated from Abbott—to $16.1 billion in 2020. billion in 2020. AbbVie’s U.S.

Competition 180

Competition Marketing Government Patients 180

PM360

JANUARY 16, 2024

EARLY BIRD DEADLINE – 09 FEBRUARY FINAL DEADLINE FOR ALL ENTRIES – 12 APRIL To visit the site please go to: [link] About The Creative Floor Awards The Creative Floor Healthcare Awards was founded in 2014 by Shaheed Peera. The aim was to help change the way award shows are run.

Healthcare 52

Healthcare Healthcare 52

PM360

JUNE 28, 2023

The Creative Floor Healthcare Awards was founded in 2014 by Shaheed Peera. Entries have come from the USA, Canada, South America, UK, EU, Australia, Japan, New Zealand, Philippines, Singapore, China, and the Middle East. The aim was to help change the way award shows are run.

Healthcare 52

Healthcare Healthcare Specialization 52

Pharma Marketing Network

JULY 17, 2023

He joined Ogilvy in 2014, as the Chief Digital Officer for Ogilvy CommonHealth, the specialist health care agency within the Ogilvy Group. Along the way, he has worked for the likes of Havas, Cushman & Wakefield and began a deep dive into the healthcare arena in 2009 when he joined Inventiv Health as Head of Digital & innovation.

Consulting 52

Consulting Education Networking Healthcare 52

World of DTC Marketing

SEPTEMBER 17, 2020

In 2019, 12 states had obesity rates in the highest category for this survey (35 percent or greater), a jump from three states in 2014, and nine in 2018. More recent state-level data from the 2019 Behavioral Risk Factor Surveillance System (BRFSS) confirm the trend that adult obesity rates continue to climb.

Healthcare 242

Healthcare Healthcare Insurance Healthcare Provider 242

World of DTC Marketing

SEPTEMBER 7, 2022

While that sounds encouraging, most cancer drugs launched between 2009 and 2014 cost more than USD 100,000 annually. COVID-19 has not impacted the number of launches in the oncology space, as 2020 and 2021 have seen similar rates of drug launches as in 2019.

Pharma 210

Pharma Food and Drug Administration Marketing Prescription 210

European Pharmaceutical Review

NOVEMBER 2, 2022

The advanced facility will be based on the Regenerative Medicine Clinic established at Cedars-Sinai in 2014, developing clinical trials for neurological, cardiovascular, musculoskeletal and autoimmune diseases. The Cedars-Sinai Board of Governors Regenerative Medicine Institute and the Smidt Heart Institute will lead the project.

Food and Drug Administration 83

Food and Drug Administration Medicine Training Electronics 83

pharmaphorum

NOVEMBER 11, 2022

Viehbacher led Sanofi between 2008 and 2014 and has decades of experience with both large pharmaceutical companies and small biotechs. However, in 2014 Sanofi fired Viehbacher over a boardroom fight regarding his management.

Insurance 40

Insurance Doctors FDA Pharma 40

Pharmaceutical Technology

MAY 16, 2023

The AMP was launched in 2014 as a partnership between the FDA , the National Institutes for Health, and several public and private organisations. BGTC will likely simultaneously work towards multiple IND applications for different diseases, she added. The BGTC was launched in October 2021, as the first AMP initiative.

Manufacturing 90

Manufacturing Medicine Patients FDA 90

Pharma Leaders

MAY 30, 2023

Abiogen Pharma has been distributing this medication in Italy since 2014 under a licence deal. Its main active agent is buffered soluble alendronate, which belongs to a class of non-hormonal pharmaceuticals, called as bisphosphonates, used in the treatment of osteoporosis.

Pharmaceutical 52

Pharmaceutical Pharma Distribution Prescription 52

World of DTC Marketing

AUGUST 31, 2022

” According to a 2014 study by the Intramural Research Program — a subsidiary of the National Institutes of Health—extreme obesity may shorten life expectancy by up to 14 years. . “Obesity rates among older Americans nearly doubled between 1988 and 2018, increasing from 22% to 40%.

Food 176

Food Government Leads Patients 176

pharmaphorum

OCTOBER 3, 2022

Translarna has had European approval for usage since 2014 and has also been available under terms similar to the MAA to DMD patients in Scotland since 2021. Last week, Sarepta Therapeutics filed for accelerated FDA approval of its DMD gene therapy developed with Roche, SRP-9001 (delandistrogene moxeparvovec).

Patients 92

Patients Medicine FDA Management 92

World of DTC Marketing

AUGUST 12, 2022

Data were mainly accessible for smaller firms, products in some therapeutic regions, orphan drugs, first-in-class drugs, therapeutic agents that received accelerated approval, and products between 2014 and 2018. The most telling data on a disconnect between drug prices and research costs has received almost no public attention.

Pharma 255

Pharma Retail Pharmaceutical manufacturing Pharmaceutical 255

Pharmaceutical Technology

APRIL 3, 2023

According to GlobalData’s Clinical Trials Database, gene therapy trials represent a 0.91% share of all planned trials in 2023, up from just 0.25% in 2014. GlobalData, the parent company of Pharmaceutical Technology, outlines a rise in gene therapy trials in 2023, in line with the growing market Fáber describes.

Media 98

Media Pharmaceutical Marketing Manufacturing 98

pharmaphorum

OCTOBER 24, 2022

The PPRS changed over time, and the 2014 PPRS first introduced a cap to NHS branded medicines spending delivered via rebates. Ann addendum to the 2014 PPRS explained that CDF spending did count in calculating rebates, but only up to pre-specified amounts, each of which was under £340 million, except for 2015/16. In or out of VPAS?

Medicine 75

Medicine Sales Specialization Marketing 75

pharmaphorum

OCTOBER 26, 2022

First approved back in 2014, it is still growing strongly, with its 2021 sales of €2.5 There are more than 200 lung disorders that can lead to pulmonary fibrosis. Boehringer is a well-established presence in the IPF treatment market with Ofev (nintedanib), one of the German drugmaker’s top-selling drugs.

Recruitment 98

Recruitment Prospecting Marketing Patients 98